Alantra has been appointed Corporate Broker to Clínica Baviera

Dec 2024

Corporate Broker

Madrid – Alantra has been appointed as Corporate Broker to Clínica Baviera and has initiated coverage through its Equity Research team.

Clínica Baviera is a leading provider of eye surgery, specializing in laser treatments for myopia and hyperopia, as well as intraocular lens procedures for presbyopia and cataracts. The company operates 134 clinics across Spain (65% of sales), Germany (20%), Italy (8%), and the UK (6%). For 2024, we project sales of €268 million, with an EBITDA margin of 27%, an EBIT margin of 20%, and approximately 40% returns on capital employed (RoCE) and equity (RoE).

Founded in 1992 by ophthalmologist Dr. Julio Baviera, Clínica Baviera has grown significantly under the leadership of his brother, Eduardo Baviera, who joined shortly after and currently serves as CEO. Eduardo has played a pivotal role in scaling the business and enhancing its operations. The company went public in 2007 and expanded its footprint in 2008 by acquiring its German business and entering the Italian market organically. In June 2024, the company furthered reinforced its international footprint by acquiring Optimax, a UK eye care company.

Please contact [email protected] if you wish to receive the full research report.